vision/eye
• patches of yellowish/whitish fundus lesions are seen in 17-60% of 12 month old and 30-100% of 18 month old mutants
• majority of lesions are in the temporal area (upper and lower) between the optic disc and equatorial region of the retina, with variable lesion size and lesions are rarely seen in the peripheral retinal areas
• 83-100% of mutants exposed to an approximate 800 lux light 6 hours/day for 6-7 months develop patches of yellowish and whitish lesions compared to 20-25% of wild-type mice
• aged and light-treated mutant retinas exhibit mitochondrial damage, vacuolization, and photoreceptor damage
• however, choroidal neovascularization is not seen in aged or 800 lux light treated mutants and induction of choroidal neovascularization using 532 nm diode laser does not differ from that seen in wild-type mice
|
• increase in Muller glial activation
|
• expression of rhodopsin, cone arrestin, and GABA are disrupted suggesting amacrine cell changes in aged mutants
|
• photoreceptor inner segment damage in aged mutants
|
• outer segment disorientation in aged mutants
|
• expression of rhodopsin, cone arrestin, and GABA are disrupted suggesting photoreceptor degeneration
|
• older mutants exhibit pigment loss in RPE cells
|
• 33% of 12 month old and 50% of 18 month old mutants exhibit retinal pigment epithelium (RPE) damage, showing altered cell junction, loss of hexagonal tessellation, and uneven distribution of F-actin
• older mutants exhibit multiple vacuoles in the RPE
• all mutants exhibit RPE lesions after light-treatment (800 Lux) compared to 20% of wild-type mice
|
• mice develop age- and light-mediated retinal damage
|
• increase in Bruch membrane thickness in aged mutants
|
pigmentation
• older mutants exhibit pigment loss in RPE cells
|
• 33% of 12 month old and 50% of 18 month old mutants exhibit retinal pigment epithelium (RPE) damage, showing altered cell junction, loss of hexagonal tessellation, and uneven distribution of F-actin
• older mutants exhibit multiple vacuoles in the RPE
• all mutants exhibit RPE lesions after light-treatment (800 Lux) compared to 20% of wild-type mice
|
nervous system
• microglial cells in aged and chronic light-treated mice show shorter and larger dendrites and larger somas
|
• increase in microglial activation as indicated by an increase in microglial cells in the inner plexiform layer and the outer plexiform layer at 18 months of age and in chronic-light treated mutants
|
• increase in Muller glial activation
|
• expression of rhodopsin, cone arrestin, and GABA are disrupted suggesting amacrine cell changes in aged mutants
|
• photoreceptor inner segment damage in aged mutants
|
• outer segment disorientation in aged mutants
|
• expression of rhodopsin, cone arrestin, and GABA are disrupted suggesting photoreceptor degeneration
|
hematopoietic system
• microglial cells in aged and chronic light-treated mice show shorter and larger dendrites and larger somas
|
• bone marrow derived macrophages exhibit reduced phagocytic activity
|
• increase in microglial activation as indicated by an increase in microglial cells in the inner plexiform layer and the outer plexiform layer at 18 months of age and in chronic-light treated mutants
|
immune system
• microglial cells in aged and chronic light-treated mice show shorter and larger dendrites and larger somas
|
• bone marrow derived macrophages exhibit reduced phagocytic activity
|
• increase in microglial activation as indicated by an increase in microglial cells in the inner plexiform layer and the outer plexiform layer at 18 months of age and in chronic-light treated mutants
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
age related macular degeneration | DOID:10871 |
OMIM:PS603075 |
J:200877 |